1. Home
  2. PW vs SILO Comparison

PW vs SILO Comparison

Compare PW & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PW

Power REIT (MD)

N/A

Current Price

$6.69

Market Cap

2.7M

Sector

Real Estate

ML Signal

N/A

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$1.80

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PW
SILO
Founded
1967
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Apparel
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.1M
IPO Year
2011
2011

Fundamental Metrics

Financial Performance
Metric
PW
SILO
Price
$6.69
$1.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.8K
★ 34.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.90
57.98
EPS
★ N/A
N/A
Revenue
★ $1,982,265.00
$72,102.00
Revenue This Year
N/A
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.32
N/A
52 Week Low
$0.50
$0.22
52 Week High
$12.92
$7.95

Technical Indicators

Market Signals
Indicator
PW
SILO
Relative Strength Index (RSI) 46.54 26.74
Support Level $6.46 $1.63
Resistance Level $8.04 $4.80
Average True Range (ATR) 0.46 0.17
MACD 0.03 0.04
Stochastic Oscillator 42.03 22.37

Price Performance

Historical Comparison
PW
SILO

About PW Power REIT (MD)

Power REIT is an internally-managed real estate investment trust that owns a portfolio of real estate assets related to transportation, energy infrastructure and Controlled Environment Agriculture in the United States. Its assets consisted of approximately 112 miles of railroad infrastructure and related real estate which is owned by its subsidiary, approximately 447 acres of fee simple land leased to a utility scale solar power generating project with an aggregate generating capacity of approximately 82 Megawatts and approximately 82 acres of land with approximately 357,000 square feet of CEA properties in the form of greenhouses. The company invested in greenhouses for state-licensed cannabis and food cultivation.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Share on Social Networks: